Earn CME Credit: https://www.naccme.com/program/7327 Knowledge is evolving regarding numerous clinical aspects of immune thrombocytopenic purpura (ITP), and there remains significant…
Browsing: Hematologic Malignancies
Minh-Ha Tran, D.O. Associate Medical Director, Transfusion Medicine, Pathology at University of California Irvine Discusses Newer Agents Coming Out For…
Minh-Ha Tran, D.O. Associate Medical Director, Transfusion Medicine, Pathology at University of California Irvine Discusses Updates On Thrombotic Microangiopathies. At…
Minh-Ha Tran, D.O. Associate Medical Director, Transfusion Medicine, Pathology at University of California Irvine Discusses Atypical Hemolytic Uremic Syndrome. At…
Minh-Ha Tran, D.O. Associate Medical Director, Transfusion Medicine, Pathology at University of California Irvine Discusses Data On TITAN Study &…
Samer Khaled, MD, Assistant Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses MEDALIST Study. At…
Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Andre Goy, MD, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical…
Elizabeth Budde, MD Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, discusses How City…
Frederick Locke, MD Program Co-Leader, Immunology Moffitt Cancer Center, discusses Management Of Toxicity With CAR-T Therapies. At The 60th ASH…
Andrew Pecora, MD Chief Innovation Officer, Professor and Vice President of Cancer Services, John Theurer Cancer Center, discusses Results Of…
Jason Butler, PhD Associate Scientist, Regenerative Medicine and Associate Professor, ?Center for Discovery and Innovation, Hackensack University, discusses Age-Associated Aberrant…
Rena Feinman, PhD Associate Scientist, Department of Research, John Theurer Cancer Center at Hackensack University Medical Center, discusses The Role…
Yana Pikman, M.D. Instructor in Pediatrics, Dana Farber Cancer Institute, Boston Childrens Hospital, Discusses The LEAP Consortium Research Outcomes. At…
Ravi Vij, MD Professor of Medicine, Oncology Division, Bone Marrow Transplantation & Leukemia, Washington University School of Medicine Discusses Data…
Jason Butler, PhD Associate Scientist, Regenerative Medicine and Associate Professor, Center for Discovery and Innovation, Hackensack University, Discusses Leukemia-Initiating Metabolic…
Yana Pikman, M.D. Instructor in Pediatrics, Dana Farber Cancer Institute, Boston Childrens Hospital, Discusses LEAP Consortium In Pediatric Acute Leukemia…
Filippo Milano, M.D., PhD Assistant Member Clinical Research Division, Associate Director Cord Blood Transplantation Cord Blood Program, Assistant Professor University…
Filippo Milano, M.D., PhD Assistant Member Clinical Research Division, Associate Director Cord Blood Transplantation Cord Blood Program, Assistant Professor University…
Filippo Milano, M.D., PhD Assistant Member Clinical Research Division, Associate Director Cord Blood Transplantation Cord Blood Program, Assistant Professor University…
Victor Chow M.D. an oncologist at the University Of Washington in Seattle, Washington discusses Understanding & Using Combo Approaches With…
Victor Chow M.D. an Oncologist at the University Of Washington in Seattle, Washington discusses Progressive Disease After Receiving CAR T…
Victor Chow M.D. an Oncologist at the University Of Washington in Seattle, Washington discusses Progression Of Disease & Treatment At…
Victor Chow M.D. an Oncologist at the University Of Washington in Seattle, Washington discusses Designing Prospective Trials At The 60th…
Victor Chow M.D. an oncologist at the University Of Washington in Seattle, Washington discusses Clinical Trials For The Future At…
Koen Van Besien, M.D. Director of the Stem Cell Transplant Program, Professor of Medicine at Weill Cornell Medical College Discusses…
Ellen Ritchie, M.D. assistant professor of medicine and a member of the Leukemia Program at the Weill Cornell Medical College…
Lee Sangmin, M.D. Assistant Professor at Weill Cornell Medical College Discusses What To Do With A Patient With Advanced CMML?…
Lee Sangmin, M.D. Assistant Professor at Weill Cornell Medical College Discusses Lenalidomide In High Risk MDS Patients at Lymphoma &…
Lee Sangmin, M.D. Assistant Professor at Weill Cornell Medical College Discusses Hypomethylating Drugs & Mutations In MDS at Lymphoma &…
Lee Sangmin, M.D. Assistant Professor at Weill Cornell Medical College Discusses How Long To Treat With Azacitidine at Lymphoma &…
Robert McBane, M.D. Practicing Hematologist & Oncologist At The Mayo Clinic in Rochester, MN Discusses ELIQUIS(Apixaban) In Non Cancer Setting…
Robert McBane, M.D. Practicing Hematologist & Oncologist At The Mayo Clinic in Rochester, MN Discusses ADAM-VTE Trial: Upper Extremity &…
Robert McBane, M.D. Practicing Hematologist & Oncologist At The Mayo Clinic in Rochester, MN Discusses ADAM-VTE Trial Overall Event Rates…
Adam Binder, M.D. Assistant Professor at Thomas Jefferson University Hospital Discusses Approving Vancomycin With Neutropenic Fever Patients At The 60th…
Shyamala Navada, M.D. Assistant Professor at Mount Sinai Health System Discusses Oral Rigosertib With Standard Dose Azacitidine At The 60th…
Robert McBane, M.D. Practicing Hematologist & Oncologist At The Mayo Clinic in Rochester, MN Discusses ADAM-VTE Trial Summary At The…
Filippo Milano, M.D., PhD Assistant Member Clinical Research Division, Associate Director Cord Blood Transplantation Cord Blood Program, Assistant Professor University…
Amer Zeidan, MBBS Assistant Professor of Medicine (Hematology) at Yale University Discusses Transfusion Independance With Hypomethylating agents At The 60th…
Amer Zeidan, MBBS Assistant Professor of Medicine (Hematology) at Yale University Discusses Is Patient Survival Based On Physician Experience At…
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Valeria Santini, MD, of the University…
EZH2 mutations are associated with a poor prognosis in myelodysplastic syndromes (MDS). In this video, recorded at the 2018 Society…
Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, held in Houston, TX, David Steensma, MD, of the…
Allogeneic stem cell transplantation (allo-SCT) is the only curative option for many patients with hematological malignancies. It is therefore crucial…
Autologous stem cell transplantation can prove to be safer in some instances compared with allogeneic transplantation for treating hematological malignancies,…
Aman Chauhan, MBBS, University of Kentucky shares Launching Phase 2 Trial In Multi-Center Fashion | Currently Evaluated in Bone Marrow…
Brian I. Rini, MD, Cleveland Clinic explains Adding Amino Modulators to Increase Efficacy | Starting to Get Complete Response Rates…
James L. Gulley, MD, PhD, FACP, National Cancer Institute, explains First In-Class Agent Targeting PD-L1 & TGF-? | There Are…
James L. Gulley, MD, PhD, FACP, National Cancer Institute, explains Combining TGF-? & PD-L1 is Developing One Drug | Very…
James L. Gulley, MD, PhD, FACP, National Cancer Institute, explains Look at Single-Agent Activity in Larger Studies | Vaccines Combining…